Page 13 - Pfizer

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

1st mRNA vax part of US-India pact; no commercial deal yet

Pfizer, Moderna Covid shots delay response in blood cancer patients

Researchers from the Icahn School of Medicine at Mount Sinai found that almost 16 per cent of patients with multiple myeloma developed no detectable antibodies after both vaccine doses.

Oxford study says mixing Covid-19 vaccines gives robust protection

This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against Covid-19

Single dose of Pfizer, Astra vaccine offers 60% protection: Lancet study

A single dose of Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection

One shot of Pfizer, AstraZeneca vax offers 60% protection against Covid

A single dose of either the Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2, the virus causing Covid-19, in adults aged 65 years and above

US warns Pfizer, Moderna vax recipients to watch for enlarged heart symptom

A new warning to watch for symptoms of an enlarged heart reported by a fraction of people receiving the Pfizer or Moderna inoculation, the Centers For Disease Control and Prevention said.

Covid LIVE: Pfizer very close to agreement with govt, says AIIMS chief

Today's coronavirus numbers: Bengaluru (803 cases), Mumbai (570 cases), Chennai (410 cases), Kolkata (172 cases), Delhi (134 cases). Stay tuned for corona-related news

Bharat Biotech, Pfizer in race for paediatric Covid-19 vax by December

Covaxin in trials already, Serum slated to start testing Novavax by July

Pfizer Covid vax provides higher antibody levels than Sinovac: Study

People who got Pfizer's Covid-19 vaccine showed "substantially higher" levels of antibodies compared to those who received China's Sinovac shots, according to a new study.

Palestinian govt cancels deal with Israel for supply of 1 mn Covid vax

The Palestinian government on Friday announced cancellation of a deal with Israel relating to the supply of around one million doses of Pfizer Covid-19 vaccine

Pfizer, Moderna preferred 2nd dose after AstraZeneca: Canadian authorities

Canada's National Advisory Committee on Immunization said Thursday people who got the AstraZeneca vaccine as their first dose should get Pfizer-BioNTech or Moderna for their second shot

Pfizer's arthritis drug can cut death risk in patients with severe Covid

The efficacy of the drug was tested on 289 patients hospitalised with severe Covid across 15 locations in Brazil.

Risk of hospitalisation doubles with Delta versus Alpha variant: Study

Vaccines from Pfizer Inc. and AstraZeneca Plc protect against delta, researchers said Monday

US to donate half bn Pfizer vaccines to low and middle-income countries

President Joe Biden plans to announce on Thursday that the US will purchase and donate half a billion (50 crore) doses of Pfizer vaccines to 92 low- and lower-middle-income countries

Top Headlines: Pfizer Covid vax's 'India price', Twitter India seeks a week

Business Standard brings top headlines on Thursday

Pfizer's Covid-19 vaccine may cost less than $10 a dose in India

Govt likely to give partial indemnity to company

Pfizer expands coronavirus vaccine tests in kids younger than 12

Pfizer says it is expanding testing of its COVID-19 vaccine in children younger than 12.

Two doses of Pfizer, Moderna vaccines cut infection risk by 91%: US CDC

Taking two doses of the Pfizer-BioNTech and Moderna's mRNA-based vaccines, authorised by the Food and Drug Administration, can reduce the risk of coronavirus infection by 91 per cent

Pfizer supports deployment of oxygen and ICU beds in Delhi, Mumbai

Around 10 per cent of these beds have been set up to meet the requirements of Covid-19 paediatric patients.

Pfizer Covid-19 jab produces less antibodies against Delta variant: Lancet

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age